Lengthy negotiation battles between GPs and corporates are hampering the German deal market. Many GPs are turning to secondary buyouts to speed up the process. Carmen Reichman reports
Activity in Germany has been slow throughout the year but as the end of summer approached, deals and exits began to surface. As everywhere in Europe, Germany battled against worsening conditions surrounding...
BPI, Hi Inov and Aurinvest renewed their support for the Parisian group as part of the investment round
Developer of sickle cell disease treatments recently rebranded from Dilaforette and announced intention to float
Transaction marks the fourth bolt-on completed by CLS with Ardian's support
Merete Haukås and Johan Nord join the rank of partners at Norway-based Cubera Private Equity